These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

141 related items for PubMed ID: 3279206

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. New inhibitors of human renin that contain novel Leu-Val replacements.
    Luly JR, Yi N, Soderquist J, Stein H, Cohen J, Perun TJ, Plattner JJ.
    J Med Chem; 1987 Sep; 30(9):1609-16. PubMed ID: 3305946
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Synthesis and renin inhibitory activity of angiotensinogen analogues having dehydrostatine, Leu psi [CH2S]Val, or Leu psi [CH2SO]Val at the P1-P1' cleavage site.
    Smith CW, Saneii HH, Sawyer TK, Pals DT, Scahill TA, Kamdar BV, Lawson JA.
    J Med Chem; 1988 Jul; 31(7):1377-82. PubMed ID: 3290486
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Renin inhibitors containing psi[CH2O] pseudopeptide inserts.
    TenBrink RE, Pals DT, Harris DW, Johnson GA.
    J Med Chem; 1988 Mar; 31(3):671-7. PubMed ID: 3279210
    [Abstract] [Full Text] [Related]

  • 7. New inhibitors of renin that contain novel phosphostatine Leu-Val replacements.
    Dellaria JF, Maki RG, Stein HH, Cohen J, Whittern D, Marsh K, Hoffman DJ, Plattner JJ, Perun TJ.
    J Med Chem; 1990 Feb; 33(2):534-42. PubMed ID: 2105396
    [Abstract] [Full Text] [Related]

  • 8. Renin inhibitors containing conformationally restricted P1-P1' dipeptide mimetics.
    Williams PD, Perlow DS, Payne LS, Holloway MK, Siegl PK, Schorn TW, Lynch RJ, Doyle JJ, Strouse JF, Vlasuk GP.
    J Med Chem; 1991 Mar; 34(3):887-900. PubMed ID: 2002469
    [Abstract] [Full Text] [Related]

  • 9. Synthesis and structure-activity relationships of human renin inhibitors designed from angiotensinogen transition state.
    Iizuka K, Kamijo T, Harada H, Akahane K, Kubota T, Etoh Y, Shimaoka I, Tsubaki A, Murakami M, Yamaguchi T.
    Chem Pharm Bull (Tokyo); 1990 Sep; 38(9):2487-93. PubMed ID: 2285979
    [Abstract] [Full Text] [Related]

  • 10. Potent in vivo inhibitors of rat renin: analogues of human and rat angiotensinogen sequences containing different classes of pseudodipeptides at the scissile site.
    Sueiras-Diaz J, Jones DM, Szelke M, Leckie BJ, Beattie SR, Beattie C, Morton JJ.
    J Pept Res; 1997 Oct; 50(4):239-47. PubMed ID: 9352462
    [Abstract] [Full Text] [Related]

  • 11. Orally potent human renin inhibitors derived from angiotensinogen transition state: design, synthesis, and mode of interaction.
    Iizuka K, Kamijo T, Harada H, Akahane K, Kubota T, Umeyama H, Ishida T, Kiso Y.
    J Med Chem; 1990 Oct; 33(10):2707-14. PubMed ID: 2120440
    [Abstract] [Full Text] [Related]

  • 12. Renin inhibitors based on novel dipeptide analogues. Incorporation of the dehydrohydroxyethylene isostere at the scissile bond.
    Kempf DJ, de Lara E, Stein HH, Cohen J, Plattner JJ.
    J Med Chem; 1987 Nov; 30(11):1978-83. PubMed ID: 3312604
    [Abstract] [Full Text] [Related]

  • 13. New renin inhibitors containing novel analogues of statine.
    Jones DM, Sueiras-Diaz J, Szelke M, Leckie BJ, Beattie SR, Morton J, Neidle S, Kuroda R.
    J Pept Res; 1997 Aug; 50(2):109-21. PubMed ID: 9273895
    [Abstract] [Full Text] [Related]

  • 14. Renin inhibitors. Synthesis of transition-state analogue inhibitors containing phosphorus acid derivatives at the scissile bond.
    Allen MC, Fuhrer W, Tuck B, Wade R, Wood JM.
    J Med Chem; 1989 Jul; 32(7):1652-61. PubMed ID: 2661820
    [Abstract] [Full Text] [Related]

  • 15. Novel renin inhibitors containing derivatives of N-alkylleucyl-β-hydroxy-γ-amino acids.
    Winiecka I, Jaworski P, Mazurek AP, Marszałek D, Goldnik A, Sokulski D.
    J Pept Sci; 2016 Feb; 22(2):106-15. PubMed ID: 26780837
    [Abstract] [Full Text] [Related]

  • 16. Renin inhibitors. I. Synthesis and structure-activity relationships of transition-state inhibitors containing homostatine analogues at the scissile bond.
    Atsuumi S, Nakano M, Koike Y, Tanaka S, Matsuyama K, Nakano M, Morishima H.
    Chem Pharm Bull (Tokyo); 1992 Feb; 40(2):364-70. PubMed ID: 1606632
    [Abstract] [Full Text] [Related]

  • 17. Design, synthesis, and evaluation of matrix metalloprotease inhibitors bearing cyclopropane-derived peptidomimetics as P1' and P2' replacements.
    Reichelt A, Gaul C, Frey RR, Kennedy A, Martin SF.
    J Org Chem; 2002 Jun 14; 67(12):4062-75. PubMed ID: 12054939
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Novel renin inhibitors containing analogues of statine retro-inverted at the C-termini: specificity at the P2 histidine site.
    Rosenberg SH, Plattner JJ, Woods KW, Stein HH, Marcotte PA, Cohen J, Perun TJ.
    J Med Chem; 1987 Jul 14; 30(7):1224-8. PubMed ID: 3298652
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.